I-Linagliptin CAS:668270-12-0 Isithombe Esifakiwe Somhlinzeki Womkhiqizi

I-Linagliptin CAS:668270-12-0 Umkhiqizi Womhlinzeki

I-Linagliptin (amagama ohwebo i-Tradjenta ne-Trajetna) iyi-inhibitor ye-dipeptidyl peptidase-4 (DPP-4) eyagunyazwa yi-US FDA ngoMeyi 2011 yokwelapha isifo sikashukela sohlobo 2 kanye nokudla nokuzivocavoca.I-Linagliptin (BI-1356) ichazwe njengezinga elinamandla lokukhetha, elihamba kancane kanye ne-inhibitor esebenza isikhathi eside ye-DPP-4.I-Linagliptin iqhamuke emizamweni yokwenza kahle ye-xanthine-based DPP-4 inhibitors ngomthofu wokuqala okhonjwe kumkhankaso we-HTS.

Oda noma Cela I-Quote

Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Isicelo kanye Nomphumela

I-Linagliptin (i-TrajentaR, i-Tradjenta TM, i-Trazenta TM, i-Trayenta TM) iyi-inhibitor yomlomo, ekhetha kakhulu ye-dipeptidyl peptidase-4 futhi iyi-ejenti yokuqala yekilasi layo okufanele iqedwe ikakhulukazi ngomzila ongeyena urenal.I-Linagliptin iboniswa ukusetshenziswa kanye ngosuku ekwelapheni abantu abadala abanesifo sikashukela sohlobo 2. I-Linagliptin inciphisa izinga likashukela egazini ngokuvimbela i-enzyme DPP-4, ngaleyo ndlela ivimbele ukuwohloka kwama-incretin hormone (i-glucagon-like peptide-1 [GLP]). -1] kanye ne-insulinotropic peptide encike ku-glucose) futhi inciphisa ukuvakasha kweglucose yangemva kokudla.

Isampula Lomkhiqizo

Ukupakishwa komkhiqizo:

Ulwazi Olwengeziwe:

Ukwakheka	I-C25H28N8O2
Isivivinyo	99%
Ukubukeka	Impushana emhlophe
Inombolo ye-CAS.	668270-12-0
Ukupakisha	25KG
I-Shelf Life	iminyaka engu-2
Isitoreji	Gcina endaweni epholile neyomile
Isitifiketi	ISO.